Compare Franklin FTSE South Korea ETF (FLKR) vs Nuvation Bio Inc. Class A Common Stock (NUVB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Franklin FTSE South Korea ETF vs Nuvation Bio Inc. Class A Common Stock — how do they compare? Franklin FTSE South Korea ETF trades at $58.12 (market cap $1.88B), while Nuvation Bio Inc. Class A Common Stock trades at $4.95 (market cap $1.71B). The key difference: Franklin FTSE South Korea ETF and Nuvation Bio Inc. Class A Common Stock are close in size by market cap, and Franklin FTSE South Korea ETF is trading nearer its 52-week high, Nuvation Bio Inc. Class A Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Franklin FTSE South Korea ETF for 15 Days and Nuvation Bio Inc. Class A Common Stock for 0 Days on average.
| FLKR | NUVB | |
|---|---|---|
Market Cap | $1.88B | $1.71B |
Volume | 709,775 | 5,448,712 |
Sector | Broad Market / Factor | Health |
52-Week High | $72.25 | $9.54 |
52-Week Low | $27.09 | $3.41 |
Typical Hold Time | 15 Days | 0 Days |
Enterprise Value | — | $1.30B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Franklin FTSE South Korea ETF
Franklin FTSE South Korea ETF seeks to track an index of South Korean equities. The fund provides exposure to companies listed in South Korea across multiple sectors.
Read more on FLKR →About Nuvation Bio Inc. Class A Common Stock
Nuvation Bio Inc. is a biopharmaceutical company focused on oncology, developing novel cancer treatments including taletrectinib (marketed as IBTROZI), a ROS1 inhibitor, and safusidenib, a brain-penetrant IDH1 inhibitor.
Read more on NUVB →
